Published in PLoS Pathog on March 16, 2017
Zika virus has oncolytic activity against glioblastoma stem cells. J Exp Med (2017) 1.40
Cancer therapy in a microbial bottle: Uncorking the novel biology of the protozoan Toxoplasma gondii. PLoS Pathog (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Rescue of measles viruses from cloned DNA. EMBO J (1995) 7.87
Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell (2015) 5.10
Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded. Nat Rev Microbiol (2008) 3.01
Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature (2011) 2.94
Remission of disseminated cancer after systemic oncolytic virotherapy. Mayo Clin Proc (2014) 2.73
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68
History of oncolytic viruses: genesis to genetic engineering. Mol Ther (2007) 2.51
Going viral with cancer immunotherapy. Nat Rev Cancer (2014) 2.27
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties. Gene Ther (2003) 2.05
Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science (2015) 1.79
New viruses for cancer therapy: meeting clinical needs. Nat Rev Microbiol (2013) 1.72
Measles virus for cancer therapy. Curr Top Microbiol Immunol (2009) 1.56
Rinderpest eradication: appropriate technology and social innovations. Science (2012) 1.44
CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy. Mol Ther (2014) 1.40
Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma. J Clin Oncol (2016) 1.32
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer. Cancer Res (2014) 1.20
Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer. J Transl Med (2013) 1.16
Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. Blood (2015) 0.93
Structural basis of efficient contagion: measles variations on a theme by parainfluenza viruses. Curr Opin Virol (2014) 0.90
Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses. Mol Ther Methods Clin Dev (2016) 0.86
Oncolytic Viruses in Cancer Treatment: A Review. JAMA Oncol (2017) 0.82
Immunizing against Anogenital Cancer: HPV Vaccines. PLoS Pathog (2016) 0.78
Thank You, Edward. Merci, Louis. PLoS Pathog (2016) 0.77